EverSource Wealth Advisors’s Niagen Bioscience NAGE Stock Holding History

EverSource Wealth Advisors’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.77K	Sell	555 -158	-22%	-$641	﹤0.01%	3769
2026 Q1	$3.14K	Buy	713 +345	+94%	+$1.86K	﹤0.01%	3478
2025 Q4	$2.34K	Sell	368 -310	-46%	-$2.16K	﹤0.01%	3450
2025 Q3	$6.33K	Sell	678 -341	-33%	-$3.44K	﹤0.01%	3042
2025 Q2	$14.7K	Buy	1,019 +815	+400%	+$8.05K	﹤0.01%	2535
2025 Q1	$1.41K	Buy	204 +194	+1,940%	+$1.22K	﹤0.01%	3092
2024 Q4	$53	Buy	+10	New	+$55	﹤0.01%	3631

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EverSource Wealth Advisors's NAGE Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Niagen Bioscience (NAGE) stake by 22% in Q2 2026, selling an estimated $641 and leaving 555 shares worth $1.77K. The position accounts for ﹤0.01% of the portfolio, ranked #3769.

EverSource Wealth Advisors first reported a position in NAGE in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.7K in Q2 2025. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

EverSource Wealth Advisors held 555 shares of Niagen Bioscience worth $1.77K as of Q2 2026.
EverSource Wealth Advisors sold 158 Niagen Bioscience shares in Q2 2026, an estimated $641.
Niagen Bioscience made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3769 holding.
EverSource Wealth Advisors first reported a position in Niagen Bioscience in Q4 2024 and has held it in 7 quarters since.
EverSource Wealth Advisors's Niagen Bioscience position peaked at $14.7K in Q2 2025.
139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.